Juvenile thyrotoxicosis; can we do better?

被引:37
作者
Birrell, G [1 ]
Cheetham, T [1 ]
机构
[1] Royal Victoria Infirm, Dept Pediat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
D O I
10.1136/adc.2003.035980
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Thyrotoxicosis remains a frustrating condition for the young person, family, and health professionals involved. The associated symptoms do not always suggest thyroid disease and patients can be unwell for many months before the diagnosis is made. The antithyroid drug regimen used to treat children and adolescents with thyrotoxicosis varies from one unit to another and yet the potentially life threatening side effects and remission rates post-treatment may be related to the regimen used. Most patients with thyrotoxicosis will need many years of drug therapy if the thyroid gland is not removed surgically or destroyed by radioiodine. Even "definitive'' treatment will typically necessitate thyroxine replacement for life.
引用
收藏
页码:745 / 750
页数:6
相关论文
共 50 条
[1]   High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease [J].
Alexander, EK ;
Larsen, PR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1073-1077
[2]   Age and gender predict the outcome of treatment for Graves' hyperthyroidism [J].
Allahabadia, A ;
Daykin, J ;
Holder, RL ;
Sheppard, MC ;
Gough, SCL ;
Franklyn, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1038-1042
[3]   Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [J].
Bartalena, L ;
Marcocci, C ;
Bogazzi, F ;
Manetti, L ;
Tanda, ML ;
Dell'Unto, E ;
Bruno-Bossio, G ;
Nardi, M ;
Bartolomei, MP ;
Lepri, A ;
Rossi, G ;
Martino, E ;
Pinchera, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :73-78
[4]   Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease [J].
Bogazzi, F ;
Bartalena, L ;
Campomori, A ;
Brogioni, S ;
Traino, C ;
De Martino, F ;
Rossi, G ;
Lippi, F ;
Pinchera, A ;
Martino, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4490-4495
[5]   Iodine-induced thyrotoxicosis in Kivu, Zaire [J].
Bourdoux, PP ;
Ermans, AM ;
Mukalay, AMW ;
Filetti, S ;
Vigneri, R .
LANCET, 1996, 347 (9000) :552-553
[6]   Evidence for a major role of heredity in Graves' disease:: A population-based study of two Danish twin cohorts [J].
Brix, TH ;
Kyvik, KO ;
Christensen, K ;
Hegedüs, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :930-934
[7]   Thyrotoxicosis incidence in Switzerland and benefit of improved iodine supply [J].
Bürgi, H ;
Kohler, M ;
Morselli, B .
LANCET, 1998, 352 (9133) :1034-1034
[8]   Ophthalmopathy in childhood Graves' disease [J].
Chan, W ;
Wong, GWK ;
Fan, DSP ;
Cheng, ACK ;
Lam, DSC ;
Ng, JSK .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (07) :740-742
[9]   Radioiodine treatment of Graves' disease in young people [J].
Cheetham, TD ;
Wraight, P ;
Hughes, IA ;
Barnes, ND .
HORMONE RESEARCH, 1998, 49 (06) :258-262
[10]   Outcome of thyroid function in Graves' patients treated with radioiodine: Role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage [J].
Chiovato, L ;
Fiore, E ;
Vitti, P ;
Rocchi, R ;
Rago, T ;
Dokic, D ;
Latrofa, F ;
Mammoli, C ;
Lippi, F ;
Ceccarelli, C ;
Pinchera, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :40-46